CELYAD ONCOLOGY SA Deferred Tax Liability Asset
CELYAD ONCOLOGY SA had Deferred Tax Liability Asset of -EUR 79.62 million as of 2022-12-31, per its 20-F filed 2023-03-23.
Discontinued › Notes › Income Taxes
ifrs-full:DeferredTaxLiabilityAsset · last filed 2023-03-23
- 2022-12-31: Deferred Tax Liability Asset -79.62M EUR.
- 2021-12-31: Deferred Tax Liability Asset -74.56M EUR.
- 2020-12-31: Deferred Tax Liability Asset -66.21M EUR.
- 2019-12-31: Deferred Tax Liability Asset -61.30M EUR.
| Period end | Deferred Tax Liability Asset | Deferred Tax Liability Asset as first filed |
|---|---|---|
| 2022-12-31 | -79.62M EUR 20-F · filed 2023-03-23 | |
| 2021-12-31 | -74.56M EUR 20-F · filed 2023-03-23 | |
| 2020-12-31 | -66.21M EUR 20-F · filed 2023-03-23 | |
| 2019-12-31 | -61.30M EUR 20-F · filed 2023-03-23 | |
| 2018-12-31 | -53.28M EUR 20-F · filed 2022-03-24 | |
| 2017-12-31 | -48.84M EUR 20-F · filed 2021-03-24 | 48.15M EUR 20-F · filed 2018-04-06 |
| 2016-12-31 | -39.37M EUR 20-F · filed 2020-03-25 | 22.65M EUR 20-F · filed 2018-04-06 |
| 2015-12-31 | -39.29M EUR 20-F · filed 2019-04-05 | 21.71M EUR 20-F · filed 2018-04-06 |